Worldwide Analytical Laboratory Services Industry to 2029 - Featuring Syneos Health, Cardinal Health, Wuxi Apptec, SGS and Eurofins Scientific Among Others - ResearchAndMarkets.com

03 Jan 2023
www.businesswire.com
DUBLIN--(BUSINESS WIRE)--The "Analytical Laboratory Services Market Analysis by Service Type, by Test Type, by End-Users, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
'Analytical Laboratory Services Market Analysis by Service Type, by Test Type, by End-Users, and by Region - Global Forecast to 2029'
An increase in market players' investment in analytical testing, rising number of drug approvals and clinical trials, initiatives of the government to improve analytical testing capacities, the rising cost of drugs and medical products, and rising need for advanced analytical testing services are some of the primary market drivers.
However, expensive advanced analytical labs, regular laboratory costs for drug development, and limitations in the analysis of new complex products are expected to restrain the market growth.
Regional Markets
In 2021, North America had the greatest share of the market due to the growing number of clinical trials, the significant investment in quality testing, the strong regulatory situation, and the region's well-established government testing facilities. However, during the projection period, Asia-Pacific is predicted to develop at the fastest CAGR.
This can be contributed to the region's rapidly growing pharmaceutical industry, an increase in the number of highly competitive and highly fragmented pharmaceutical companies, increased government spending to establish new laboratories, and increased government spending on healthcare in Asian countries.
Companies Mentioned
Covance (a subsidiary of laboratory corporation of america holdings) (US)
Wuxi Apptec (China)
SGS S.A (Switzerland)
European Medicines Agency (European Union)
Central Drugs Standard Control Organization (India)
Evotec se (Germany)
Agenzia italiana del farmaco - aifa (italy)
Pharmaceutical Research Associates Inc. (US)
ALS LimitedALS Limited (Australia)
Market Segmentation:
Service Type (Revenue, USD Million)
Stand-alone Laboratories
Hospital-based Laboratories
Clinics based Laboratories
Test Type (Revenue, USD Million)
Stability Testing
Bioanalytical Testing
Method Validation
Raw Material Testing
Batch Release Testing
Physical Characterization
Environmental Monitoring
Microbial Testing
End-Users (Revenue, USD Million)
Others
By Region (Revenue, USD Million)
North America
U.S
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/etdobc
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.